Laser photocoagulation for choroidal neovascularization in age-related macular degeneration

Age-Related Macular Degeneration

Volumn , Issue , 2002, Pages 181-201

  Yoken, Jonathan ^a   Duncan, Jacque L ^a   Berger, Jeffrey W ^a   Dunaief, Joshua L ^a   Fine, Stuart L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 16844374584     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (54)

1. Fine SL, Berger JW, Maguire MG, Ho AC. Age-related macular degeneration. N Engl J Med 2000;342:483-92.
2. Ferris FL III, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984;102:1640-1642.
3. Patz A, Fine SL, Finkelstein D, Yassur Y. Diseases of the macula: the diagnosis and management of choroidal neovascularization. Trans Am Acad Ophthalmol Otolaryngol 1977;83:468-475.
4. Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1982;100:912-918.
5. Treatment of Age Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol 1999;117:1329-1345.
6. Fine SL. Further thoughts on the diagnosis and treatment of patients with macular degeneration. Arch Ophthalmol 1983;101:1189-1190.
7. Fine SL. Macular Photocoagulation Study. Arch Ophthalmol 1980;98:832.
8. Macular Photocoagulation Study Group. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol 1986;104:503-512.
9. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Arch ophthalmol 1990;108:816-824.
10. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year, results from randomized clinical trials. Arch Ophthalmol 1994;112:500-509.
11. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991;109:1242-1257.
12. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991;109:1232-1241.
13. Berger JW, Fine SL. Laser treatment for choroidal neovascularization. In: Berger Fine SL, Maguire MG, eds. Age-Related Macular Degeneration. St. Louis: CV Mosby, 1999: 279-296.
14. Chamberlin JA, Bressler NM, Bressler SB, Elman SJ, Murphy RP, Flood TP, Hawkins BS, Maguire MG, Fine SL. The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study. The Macular Photocoagulation Study Group. Ophthalmology 1989;96:1526-1534.
15. Macular photocoagulation Study Group. Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the Macular Photocoagulation Study. Arch Ophthalmol 1994;112:1176-1784.
16. Macular photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Arch Ophthalmol 1991;109:1109-1114.
17. Macular photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol 1990;108:825-831.
18. Macular Photocoagulation Study Group. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Arch Ophthalmol 1996;114:400-412.
19. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of randomized clinical trial. Arch Ophthalmol 1991;109:1220-1231.
20. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol 1993;111:1200-1209.
21. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Arch Ophthalmol 1994;112:489-499.
22. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for sub-foveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Arch Ophthalmol 1994;112:480-488.
23. Stevens TS, Bressler NM, Maguire MG, Bressler SB, Fine SL, Alexander J, Phillips DA, Margherio RR, Murphy PL, Schachat AP. Occult choroidal neovascularization in age-related macular degeneration. A natural history study. Arch Ophthalmol 1997;115:345-350.
24. Soubrane G, Coscas G, Francais C, Koenig F. Occult subretinal new vessels in age-related macular degeneration. Natural history and early laser treatment. Ophthalmology 1990;97:649-657.
25. Barondes MJ, Pagliarini S, Chisholm IH, Hamilton AM, Bird AC. Controlled trial of laser photocoagulation of pigment epithelial detachments in the elderly: 4 year review. Br J Ophthalmol 1992;76:5-7.
26. Maguire JI, Benson WE, Brown GC. Treatment of foveal pigment epithelial detachments with contiguous extrafoveal choroidal neovascular membranes. Am J Ophthalmol 1990;109:523-529.
27. Singerman LJ, Stockfish JH. Natural history of subfoveal pigment epithelial detachments associated with subfoveal or unidentifiable choroidal neovascularization complicating age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1989;227:501-507.
28. Meredith TA, Braley RE, Aaberg TM. Natural history of serous detachments of the retinal pigment epithelium. Am J Ophthalmol 1979;88:643-651.
29. Poliner LS, Oik RJ, Burgess D, Gordon ME. Natural history of retinal pigment epithelial detachments in age-related macular degeneration. Ophthalmology 1986;93:543-551.
30. Elman MJ, Fine SL, Murphy RP, Patz A, Auer C. The natural history of serous retinal pigment epithelium detachment in patients with age-related macular degeneration. Ophthalmology 1986;93:224-230.
31. Coscas G, Soubrane G, Ramahefasolo C, Fardeau C. Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991;109:1258-1265.
32. Orth DH, Rosculet JP, De Bustros S. Foveal sparing photocoagulation for exudative age-related macular degeneration. Retina 1994;14:153-159.
33. Tornambe PE, Poliner LS, Hovey LJ, Taren D. Scatter macular photocoagulation for subfoveal neovascular membranes in age-related macular degeneration. A pilot study. Retina 1992;12:305-314.
34. Buzney SM, Weiter JJ, Freilich BD. Scatter macular photocoagulation for age- related subfoveal neovascularization (ARVO abstract). Invest Ophthalmol Vis Sci 1995;36:S225.
35. Midena E, Valenti M, Piermarocchi S, Bertoja E, Degli-Angeli C, Segato T. Functional effects of scatter macular photocoagulation for age-related subfoveal neovascularization (ARVO abstract). Invest Ophthalmol Vis Sci 1996;37:S111.
36. Soubrane G, Coscas G. Photocoagulation of poorly defined choroidal neovascular membranes associated with age-related macular degeneration. In: Lewis H, Ryan SJ, eds. Medical and surgical retina: advances, controversies, and management. St. Louis: Mosby, 1994:48-53.
37. Bressler NM, Maguire MG, Murphy PL, Alexander J, Margherio R, Schachat AP, Fine SL, Stevens TS, Bressler SB. Macular scatter (“grid”) laser treatment of poorly demarcated sub-foveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial. Arch Ophthalmol 1996;14:1456-1464.
38. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol 1988;32:375-413.
39. Kogure K, Choromokos E. Infrared absorption angiography. J Appl Physiol 1969 26:154-157.
40. Lim JI, Sternberg P Jr, Capone A Jr, TM Sr, Gilman JP. Selective use of indocyanine green angiography for occult choroidal neovascularization. Am J Ophthalmol 1995;120:75-82.
41. Yannuzzi LA, Slakter JS, Sorenson JA, Guyer DR, Orlock DA. Digital indocyanine green videoangiography and choroidal neovascularization. Retina 1992;12:191-223.
42. Regillo CD, Benson WE, Maguire JI, Annesley WH Jr. Indocyanine green angiography and occult choroidal neovascularization. Ophthalmology 1994;101:280-288.
43. Guyer DR, Yannuzzi LA, Ladas I, Slakter JS, Sorenson JA, Orlock D. Indocyanine green-guided laser photocoagulation of focal spots at the edge of plaques of choroidal neovascularization. Arch Ophthalmol.1996;114:693-697.
44. Kwun RC, Guyer DR. Indocyanine green angiography. In: Berger JW, Fine SL, Maguire MG, eds. Age-Related Macular Degeneration. St. Louis: CV Mosby, 1999:237-247.
45. Lim JI, Aaberg TM, Capone A Jr, Sternberg P Jr. Indocyanine green angiography-guided photocoagulation of chroidal neovascularization associated with retinal pigment epithelial detachment. Am J Ophthalmol 1997;123:524-532.
46. Slakter JS, Yannuzzi LA, Sorenson JA, Guyer DR, Ho AC, Orlock DA. A pilot study of indocyanine green videoangiography-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol 1994;112:465-472.
47. Sorenson JA, Yannuzzi LA, Slakter JS, Guyer DR, Ho AC, Orlock DA. A pilot study of digital indocyanine green videoangiography for recurrent occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol 1994;112:473-479.
48. Weinberger AW, Knabben H, Solbach U, Wolf S. Indocyanine green guided laser photocoagulation in patients with occult choroidal neovascularisation. Br J Ophthalmol 1999;83:168-172.
49. Glaser BM, Murphy RP, Lakhanapal RR, Lin SB, Baudo TA. Identification and treatment of modulating choroidal vessels associated with occult choroidal neovascularization (ARVO abstract). Invest Opthalmol Vis Sci 2000;41:S320.
50. Husain D, Gragoudas ES, Miller JW. Photodynamic Therapy. In: Berger JW, Fine SL, Maguire MG, eds. Age-Related Macular Degeneration. St. Louis: CV Mosby, 1999: 297-307.
51. Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Lagua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol 1999;117:1161-1173.
52. Schmidt-Erfurth U, Miller JW, Sickenberg M, Lagua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Borg H, Strong A, Man-juris U, Gray T, Fsedni M, Bressier NM. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol 1999;117:1177-1187.
53. Freund KB, Yannuzzi LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 1993;115:786-791.
54. Schachat AP. Review of ongoing clinical trials for AMD. American Academy of Ophthalmology, Vitreoretinal Update, Orlando, Florida, 1999.